Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.
about
A new horizon of moyamoya disease and associated health risks explored through RNF2132D DIGE Does Not Reveal all: A Scotopic Report Suggests Differential Expression of a Single "Calponin Family Member" Protein for Tetany of Sphincters!Moyamoya disease and syndromes: from genetics to clinical managementMoyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cellsHypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathwaySensitivity to Sevoflurane anesthesia is decreased in mice with a congenital deletion of Guanylyl Cyclase-1 alpha.Frequency and significance of rare RNF213 variants in patients with adult moyamoya diseaseThe fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.Can whole-exome sequencing data be used for linkage analysis?Non-linear interactions between candidate genes of myocardial infarction revealed in mRNA expression profiles.Regulation of Neuronal Oxygen Responses in C. elegans Is Mediated through Interactions between Globin 5 and the H-NOX Domains of Soluble Guanylate Cyclases.Of von Willebrand factor and platelets.Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial.Consensus statement on current and emerging methods for the diagnosis and evaluation of cerebrovascular disease.RNF213 Is Associated with Intracranial Aneurysms in the French-Canadian Population.Furthering the debate on the role of interstitial cells of Cajal in enteric inhibitory neuromuscular neurotransmission.Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.Juvenile Moyamoya and Craniosynostosis in a Child with Deletion 1p32p31: Expanding the Clinical Spectrum of 1p32p31 Deletion Syndrome and a Review of the LiteratureStimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants.cGMP Signaling and Vascular Smooth Muscle Cell Plasticity.Structure/function of the soluble guanylyl cyclase catalytic domain.
P2860
Q28080728-B69089B9-EDD9-4D50-B394-1EF4C3566FDDQ28082341-669F2DFD-DD99-4843-9B5F-EFB114C535DFQ28086795-81B94BB0-82CD-4D3E-B698-FC113A78D1D7Q28116611-B645579B-BD97-4A0F-81F5-80B9FFDF8ACFQ33683635-35FA534C-CD9F-4FB2-8A68-B3A97078E919Q33801187-4BB16B01-8858-4D46-9148-7BEFE4AFA9D4Q33803265-D64E2449-950E-461D-A67D-3A2359D8313DQ34042836-5DC45964-E188-43E0-8FF4-1487F877970EQ35691239-9BECE8BB-5F48-467D-BB74-FEF6720A94FDQ36136544-AFF2BDE6-44CB-4098-B0C7-C61B42F3766BQ36480286-B6A6F59A-7285-4A10-8AAE-489B2F48037BQ38258281-004207CF-EBE6-4857-8641-CA4E155F3AAAQ38372797-BAC15119-B887-4B41-8EDC-2B6008AFDA1CQ38641106-5898AA55-F403-4ABB-980C-B9DB2CEA6A88Q39286785-1A3B7026-1189-40AC-9967-DE2370E9F179Q39625867-B54176B1-7455-493C-8DB7-0A588B7EFBC0Q41637594-3D1D75C2-C3F2-4955-A243-9041F42493F3Q42365761-CD4D30FC-5B9B-4626-8E3E-8E23A102A467Q51682930-41654EA3-A2B5-47C0-B082-7ED55129516EQ52578398-B74BA1B5-E581-4088-BE7D-EE1EED9924BDQ55436230-8C4B1386-C409-4CDD-AF78-D66312401112
P2860
Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Loss of α1β1 soluble guanylate ...... ads to moyamoya and achalasia.
@en
Loss of α1β1 soluble guanylate ...... ads to moyamoya and achalasia.
@nl
type
label
Loss of α1β1 soluble guanylate ...... ads to moyamoya and achalasia.
@en
Loss of α1β1 soluble guanylate ...... ads to moyamoya and achalasia.
@nl
prefLabel
Loss of α1β1 soluble guanylate ...... ads to moyamoya and achalasia.
@en
Loss of α1β1 soluble guanylate ...... ads to moyamoya and achalasia.
@nl
P2093
P2860
P50
P1476
Loss of α1β1 soluble guanylate ...... ads to moyamoya and achalasia.
@en
P2093
Audrey Delaforge
Aurore Essongue
Christian Sainte-Rose
Eliane Berrou
Emmanuel Houdart
Francoise Bergametti
Frédéric Adam
Kareen Billiemaz
Marilyne Lebret
Maryjke Bryckaert
P2860
P304
P356
10.1016/J.AJHG.2014.01.018
P407
P50
P577
2014-02-27T00:00:00Z